GlaxoSmithKline Q3 Net declines 34% to Rs 101 cr

Company's total income declined by 7% to Rs 666 crore in the July-September quarter

Drug firm GlaxoSmithKline Pharmaceuticals (GSK) today reported 33.73% decline in standalone net profit at Rs 100.95 crore for the third quarter ended September 30, 2013.

The company had posted a standalone net profit of Rs 152.34 crore in the same period previous fiscal, GSK Pharma said in a filing with the BSE.

The company follows January to December financial year.

The company's total income declined by 7.02% to Rs 666.02 crore in the July-September quarter, compared to Rs 716.37 crore during the same period last year.

GlaxoSmithKline Pharmaceuticals shares were trading at Rs 2,448 per scrip at BSE in the afternoon trade, down 1.33% from their previous close.